Smith, Salley & Associates Neogenomics Inc Transaction History
Smith, Salley & Associates
- $1.48 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding NEO
# of Institutions
294Shares Held
124MCall Options Held
698KPut Options Held
120K-
Black Rock Inc. New York, NY19.7MShares$337 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$241 Million0.0% of portfolio
-
Brown Advisory Inc6.89MShares$118 Million0.13% of portfolio
-
Janus Henderson Group PLC London, X06.6MShares$113 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.54MShares$112 Million0.06% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $2.16B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...